Kidney Week

Author Requirements

• Abstract Submitters must have an ASN User Login in order to create and submit an abstract.
• ALL abstract authors (including co-authors) must do the following BEFORE they can be added to an abstract. Please tell your authors to complete these steps as soon as possible:
  • Create an ASN User Login, if they do not already have one.
    • Click here if the Submitter/author needs to create a User Login (free, ASN membership not required).
    • Click here if the Submitter/author has a User Login but forgot his/her password.
  • Provide 24 months of FULL disclosures.
    • Authors must submit their OWN disclosures.
    • Disclosures provided in 2023 will not be accepted – disclosures must be provided or updated in the current calendar year (2024) to be considered current.
    • Click here for the ASN Conflict of Interest and Disclosure Policy.
    • Please allow adequate time to gather this information before the submission deadline.
• ASN membership is not required to submit, be an author on, or present an abstract.
• The Presenting (First) Author of an accepted oral or poster abstract must register for the Annual Meeting (fees apply).
• ASN has adopted the criteria recommended by the International Committee of Medical Journal Editors (ICMJE) in the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals: "authorship be based on...1. Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND 2. Drafting the work or revising it critically for important intellectual content; AND 3. Final approval of the version to be published; AND 4. Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved."
• NEW! Based on the above ICMJE criteria for authorship, artificial intelligence (AI) tools, such as ChatGPT, do not qualify for authorship.
• ASN requires that ALL authors have full access to all study data and statistical analyses of the data. If that is not the case, the abstract may be rejected or retracted.
• If the Presenting Author or Submitter's contact information changes after submission, please email kidneyweek@asn-online.org to confirm the new email address. Updating the email address associated with an ASN profile does not automatically update it in the abstract submission system.

Content Eligibility

• All research abstracts, clinical case reports, informational posters, and late-breaking clinical trials must be submitted electronically through the ASN abstract submission site by their respective deadlines for consideration. Please refer to the Important Dates and Deadlines below.
• Submission of multiple abstracts on a single study may result in the rejection of one or more of the abstracts.
• Abstracts are NOT eligible for consideration if the research will have been presented at another meeting or press conference prior to Kidney Week.
• Abstracts are NOT eligible for consideration if the research has been published or accepted for publication by May 22, 2024.
• Posting of un-refereed manuscripts to a community preprint server by authors will not be considered prior publication, provided that the following conditions are met:
  • During submission, authors must acknowledge preprint server deposition.
  • Versions of a manuscript that have been altered as a result of the peer review process may not be deposited.
  • The preprint version cannot be indexed (e.g., in MEDLINE or PubMed).
  • Upon ASN publication, authors are responsible for updating the archived preprint version with a link to the ASN Abstract Supplement PDF.
    • The preprint server should meet NIH standards for interim research product repositories.
• All research and studies in submitted abstracts must comply with the WMA Declaration of Helsinki, the Declaration of Istanbul on Organ Trafficking and Transplant Tourism, and the NIH Guide for the Care and Use of Laboratory Animals.
• NEW! If AI tools, such as ChatGPT "are used to create content or assist with writing or manuscript preparation, authors must take responsibility for the integrity of the content generated by these tools. Authors should report the use of artificial intelligence, language models, machine learning, or similar technologies to create content or assist with writing or editing of manuscripts in the Methods section if this is part of formal research design or methods. This should include a description of the content that was created or edited and the name of the language model or tool, version and extension numbers, and manufacturer. (Note: this does not include basic tools for checking grammar, spelling, references, etc.)" [JAMA Network Authorship Criteria and Contributions]
• NEW! "The submission and publication of images created by artificial intelligence, machine learning tools, or similar technologies is discouraged, unless part of formal research design or methods, and is not permitted without clear description of the content that was created and the name of the model or tool, version and extension numbers, and manufacturer. Authors must take responsibility for the integrity of the content generated by these models and tools." [JAMA Network Statistical Methods and Data Presentation]

Important Dates and Deadlines

Submission Deadline

• Research abstracts and clinical case reports ("abstracts") must be submitted by 2:00 p.m. EDT (Eastern time) on Wednesday, May 22, 2024. Abstracts may be edited and re-submitted until the deadline. Abstracts that are unpaid or have payment issues will not be considered. If the Submitter does not receive a payment confirmation email titled "Abstract Payment Confirmation," please check for it in spam/junk folders, then email kidneyweek@asn-online.org to confirm the abstract's submission status.

Changes

• Through May 22, 2024, at 2:00 p.m. EDT, submitted abstracts may be returned to draft, edited, and re-submitted by logging into the ASN abstract submission site. Because only the Submitter has access to the abstract, s/he will need to make any changes.
  • Between this date/time and May 29, 2024, for submitted abstracts needing minimal changes, the Submitter or Presenting (First) Author can email kidneyweek@asn-online.org with the abstract number in the subject line and the ASN Abstract Change Form attached.
  • After May 29, 2024, no changes will be allowed, including author updates.

Notifications

• ASN will email notifications to the Presenting (First) Authors and Submitters of all research abstract, clinical case report, and informational poster submissions by 11:59 p.m. EDT on August 9, 2024.
• Please refer to Notification for more details.

Withdrawals

• The Presenting (First) Author can request abstract withdrawal through June 30, 2024, by emailing kidneyweek@asn-online.org. Please note the abstract number in the email subject line and the Presenting (First) Author's name in the email body. The $75 processing fee is nonrefundable. After June 30, withdrawal requests will be accepted on a case-by-case basis, but the abstract may still appear in meeting publications.

Informational Posters

• The informational poster submission period opens on June 12, 2024, and closes on July 3, 2024, 2:00 p.m. EDT.

Late-Breaking Clinical Trials

• The late-breaking clinical trials submission period opens on July 17, 2024, and closes on September 4, 2024, 2:00 p.m. EDT.

Publication

• Abstracts accepted for oral presentations, posters, and publication will be included in the ASN Abstract Supplement PDF, which will be posted online on October 11, 2024.

Submission Types

Research Abstracts

• All types of nephrology-related research are eligible for submission and should address scientific questions, detail clinical observations, or contain preliminary original scientific data.
• There is no limit to the number of research abstracts that an individual may submit, but only one abstract per study should be submitted. Submission of multiple abstracts on a single study may result in the rejection of one or more of the abstracts.
• Accepted research abstracts may be assigned for oral presentation, assigned for poster presentation, and/or published in the ASN Abstract Supplement PDF.
• Important! If your research data are available by May 22, 2024, ASN strongly recommends that you submit your abstract during the regular call for abstracts, rather than holding it for the call for late-breaking clinical trials. The regular call for abstracts has more opportunities for oral presentations and posters than the call for late-breaking clinical trials.

Clinical Case Reports

• Case reports must include uniqueness of the case, clinical findings presented, outcomes documented, and "take-away" lessons (teaching points).
• There is a limit of 2 case report submissions per Presenting (First) Author.
• Accepted case reports may be assigned for poster presentation and/or published in the ASN Abstract Supplement PDF (generally not assigned for oral presentation).

Informational Posters

• Informational Poster submissions will be accepted June 12 - July 3, 2024, 2:00 p.m. EDT.
• Submissions must include research services in core facilities at academic or nonprofit institutions as well as ongoing clinical trials open to enrollment. The purpose is to stimulate utilization of research core facilities and enrollment in clinical trials.
• Abstracts describing clinical trial results are NOT eligible for consideration.
• Accepted informational posters will be assigned for poster presentation but will not be published in the ASN Abstract Supplement PDF.

Late-Breaking Clinical Trials

• Late-Breaking Clinical Trial submissions will be accepted July 17 - September 4, 2024, 2:00 p.m. EDT. Guidelines and instructions specific to late-breaking submissions will be posted in July.
• Accepted late-breaking clinical trials may be assigned for oral presentation, assigned for poster presentation, and/or published in the ASN Abstract Supplement PDF.

Submission Details

How To Submit

• All research abstracts, clinical case reports, informational posters, and late-breaking clinical trials must be submitted electronically through the ASN abstract submission site during their respective submission periods. Please refer to the Important Dates and Deadlines above.
• The abstract submission may be completed on the first visit to the submission site or may be saved and completed at a later time. An abstract may be submitted and paid for, then returned to draft, edited, and resubmitted for no additional fee by May 22, 2024, at 2:00 p.m. EDT.
• It is important that the Presenting (First) Author verifies the abstract data BEFORE submission. Carefully review the "View Proof" link at the bottom of Step 6 in the submission; how the abstract appears in the proof is how it will be published.
• The $75 processing fee per research abstract, clinical case report, or informational poster submission is nonrefundable. The processing fee must be paid at the time of submission by credit card (American Express, MasterCard, or VISA).
• Upon abstract submission, the Presenting (First) Author and co-authors agree to all copyright transfer terms and the ASN embargo policy.
• If accepted for presentation/publication, abstracts will be printed as they were submitted with any changes as of May 29, 2024. ASN has the authority to make standard copyediting changes (e.g., spelling errors, capitalizations, abbreviations).
• For guidance on making changes to a submitted abstract, requesting withdrawal of an abstract, and notification details, please refer to the Important Dates and Deadlines above.

Character Limit

• An abstract submission may contain a maximum of 2,500 characters. The total character count includes characters and spaces in the following fields:
  • Title
  • Body
  • Figure(s)
    • Up to 2 figures can be included in a submission
    • Figure count is determined by image height but will not exceed 560 characters
    • Because image height cannot be calculated manually, we recommend uploading, editing, and replacing figures in the submission until an acceptable quality : character ratio is reached
  • Table
    • Up to 1 table can be included in a submission
    • Table count is 50 characters per row
    • For complex tables and in situations where control over formatting is desired, we recommend uploading the table as a figure
  • Author names (as they appear once added on Step 4 of the submission process)
    • Author institutions do not count towards the total characters

Submission Fields

Assignment

All abstract submissions are peer reviewed, and authors' names and institutions are blinded to reviewers.

Accepted abstracts will be assigned to one of the following:

"High-impact Clinical Trials" Oral Sessions

• For late-breaking clinical trial submissions only.
• Information specific to late-breaking submissions will be posted in July.

Oral Abstract Sessions

• These sessions will be held in-person in San Diego, CA from 4:30-6:00 p.m. PDT on the following dates:
  • Thursday, October 24
  • Friday, October 25
  • Saturday, October 26
• These sessions will be recorded for later viewing.

Posters

• Posters will be presented in-person in San Diego, CA from 9:30 a.m. - 2:30 p.m. PDT, in the exhibit hall, on the following dates:
  • Thursday, October 24
  • Friday, October 25
  • Saturday, October 26
• If accepted for poster presentation, the Presenting (First) Author or a co-author must be available at the poster board at 10:00 a.m. - 12:00 p.m. PDT for presentation and discussion.
• Poster presenters are encouraged to submit an ePoster to complement their printed poster. ePosters will be available for viewing online starting Thursday, October 24, 10:00 a.m. PDT.

Publication Only

• Some abstracts will be included in the ASN Abstract Supplement PDF but not presented during Kidney Week.
• To request removal from the Abstract Supplement if an abstract is selected for Publication Only, the Presenting (First) Author must check the box during the submission process that states: "Please do not include my abstract in the ASN Abstract Supplement if my abstract is not selected for an oral or poster presentation."

Notification

• ASN will email notifications to the Presenting (First) Authors and Submitters of all research abstract, clinical case report, and informational poster submissions by 11:59 p.m. EDT on August 9, 2024.
• It is the responsibility of the Presenting (First) Author to share the notification with their co-authors.
• If you are a Presenting Author and have not received your notification by August 10, 2024, please check for it in spam/junk folders, then email kidneyweek@asn-online.org; note the abstract number in the email subject line and the Presenting Author's name in the email body.
• If the Presenting Author or Submitter's contact information changes after submission, please email kidneyweek@asn-online.org to confirm the new email address. Updating the email address associated with an ASN profile does not automatically update it in the abstract submission system.

Presentation

• The Presenting Authors of abstracts accepted for oral or poster presentations must register for the Annual Meeting (fees apply) and travel to San Diego, CA to present in-person.

Confidential Advanced Access

All abstracts submitted in connection with Kidney Week are disclosed to ASN's peer review committee, employees, and contractors as necessary. Although ASN and its employees or contractors cannot guarantee the confidentiality of submitted abstracts, every effort will be made to ensure confidentiality of submitted material.